Business

20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries

OSAKA, Japan & CAMBRIDGE, Mass., September 23, 2025--Takeda (TOKYO:4502/NYSE: TAK) today committed JPY 4.6 billion (approx. USD 32.1 million) to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to building climate-resilient health systems in low- and middle-income countries around the world. Amid rising temperatures and extreme weather events, Takeda recognizes an urgent need to ensure that healthcare remains resilient and accessible, par

articleTakeda Pharmaceutical Co. Ltd.September 23, 202510/company/takeda-pharmaceutical-co-ltd/news/20000-takeda-employees-voted-to-select-four-new-global-corporate-social-responsibility-collaborations-to-advance-climate-resilient-health-systems-in-94-countries
20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries

About this update from Takeda Pharmaceutical Co. Ltd.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/21cae400fbf08cda2ef53a38dc9aaa95"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uRj2dbyZW9Cxh7UFEItzAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/21cae400fbf08cda2ef53a38dc9aaa95","width":480,"height":320}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"More Than 20,000 Takeda Employees Across 80 Countries and Regions Voted to Select the FY2025 New Awardees: International Medical Corps (IMC), the Society of Critical Care Medicine (SCCM), the United Nations Office for Project Services (UNOPS) Bangladesh, and Vitamin Angels","length":273,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Takeda’s Four New Collaborations—A Commitment of JPY 4.6 Billion (Approx. USD 32.1 Million)—Boost the Total Global CSR Program Contributions to JPY 33.4 Billion (Approx. USD 238.7 Million) Across 38 Diverse Collaborations Worldwide and Extend Our Reach to an Additional 26.6 Million Direct Beneficiaries","length":303,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Takeda’s Global CSR Program Expects to Reach 53.7 Million People in 94 Countries by 2030","length":88,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":664,"olType":false},{"type":"text","content":"OSAKA, Japan & CAMBRIDGE, Mass., September 23, 2025--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE: TAK) today committed JPY 4.6 billion (approx. USD 32.1 million) to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to building climate-resilient health systems in low- and middle-income countries around the world. Amid rising temperatures and extreme weather events, Takeda recognizes an urgent need to ensure that healthcare remains resilient and accessible, particularly in regions most susceptible to the impacts of climate change. Climate action is critically underfunded, receiving less than 2% of philanthropic funding.*1 Through its FY2025 collaborations, Takeda is deepening its focus on supporting the world’s most vulnerable communities, addressing the greatest threats to health systems worldwide. This ren...

More updates from Takeda Pharmaceutical Co. Ltd.

health systemsGlobal Corporate Social Responsibilityhealth outcomesTakeda